Related Experiment Video
Updated: Jun 18, 2026

08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
[Programming nutritional and metabolic disorders: the diabetic environment during gestation]
Summary
Fetal development significantly impacts adult health, with both poor and excess fetal growth increasing risks for metabolic syndrome and cardiovascular diseases. Epigenetic factors play a key role in transmitting these risks across generations.
Area of Science:
- Developmental biology
- Public health
- Epigenetics
Background:
- Rising rates of obesity, metabolic disorders, and cardiovascular diseases (CVD) are a global concern.
- Cardiovascular disease risk factors are increasingly identified in infancy, often programmed during fetal development.
- The concept of 'fetal programming' links early-life environment to long-term health outcomes.
Purpose of the Study:
- To explore the concept of fetal programming and its role in metabolic syndrome and CVD.
- To highlight the impact of both poor and excess fetal growth on adult disease risk.
- To emphasize the contribution of epigenetic mechanisms to intergenerational health effects.
Main Methods:
- Review of existing literature on fetal programming.
- Analysis of studies linking early-life environment to adult metabolic and cardiovascular health.
- Examination of epigenetic mechanisms involved in developmental programming.
Main Results:
- Both restricted and excessive fetal growth, such as in pregnancies with maternal diabetes, are associated with increased adult risks.
- Metabolic syndrome, a cluster of CVD risk factors, is increasingly prevalent in youth, particularly with obesity.
- Altered intrauterine environments can lead to adaptations that are transmitted across generations, contributing to adult disease burden.
Conclusions:
- Fetal programming, influenced by the intrauterine environment and epigenetic modifications, plays a critical role in lifelong and intergenerational health.
- Preventive public health programs targeting early life are essential to mitigate the long-term consequences of fetal programming.
- Understanding these mechanisms is crucial for addressing the increasing prevalence of metabolic disorders and cardiovascular diseases.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
